酪氨酸蛋白激酶受体C,tyrosine protein kinase C (TrkC)
1)tyrosine protein kinase C (TrkC)酪氨酸蛋白激酶受体C
2)RPTK受体型蛋白酪氨酸激酶
3)receptor tyrosine protein kinase受体酪氨酸蛋白激酶
1.Recent emerging evidence suggests that the activiation ofreceptor tyrosine protein kinase induced by phosphatidylinositol 3-kinase,protein kinase C and Ca2+ plays a key role in the development of CNV.研究证实,磷脂酰肌醇激酶、蛋白激酶C和Ca2+等参与活化受体酪氨酸蛋白激酶的信号通路,以及受体酪氨酸蛋白激酶的持续活化对CNV的发生发展起关键性作用。
2.Receptor tyrosine protein kinase is one of key kinases in cell signal transduction and plays an important role in the process of cell growth, development and functions regulated by growth factors.受体酪氨酸蛋白激酶是细胞信号转导进行的关键信号酶,在生长因子调控细胞生长、发育与功能的过程中起着重要的生理作用。
英文短句/例句
1.Project Epidermal Growth Factor Receptor Tyrosine Protein Kinase Inhibitor Screen Model;表皮生长因子受体酪氨酸蛋白激酶抑制剂筛选模型建立
2.Effects of Diet Fat and Endurance Training on Insulin Receptor TyrosineProtein Kinase in Obese Rats;饮食脂肪含量和耐力运动对肥胖鼠胰岛素受体酪氨酸蛋白激酶的影响
3.Experimental Studies on Rat Bone Marrow Stromal Cells Modified with Protein-tyrosine Kinase Receptor B Gene;蛋白酪氨酸激酶受体B基因修饰骨髓基质细胞的实验研究
4.Regulation of EPHB6 receptor tyrosine kinase on the ERK signaling pathwayEPHB6受体型酪氨酸蛋白激酶对ERK信号通路的调控效应
5.Expression of receptor tyrosine kinase EphA1 protein in gastric cancer and its clinicopathological significance胃癌中受体酪氨酸激酶人类肝细胞癌细胞系A1蛋白的表达
6.Preliminary Research of RAI16 Protein Interacting with Tec Tyrosine Kinase;Tec酪氨酸激酶作用蛋白RAI16的初步研究
7.Construction of cell model based on reporter gene for identifying agonist of insulin receptor protein-tyrosine kinase基于报告基因的胰岛素受体蛋白酪氨酸激酶激动剂细胞筛选模型的建立
8.The Expression of PTPRO Gene Was Regulated by MiR-17-92 Cluster;受体型蛋白酪氨酸磷酸酶O（PTPRO）基因的表达受MiR-17-92簇调控
9.Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
10.Effects of Src family kinases on gap junction Cx43 in formation of cortical cataractSrc-家族酪氨酸激酶对皮质性白内障晶状体中缝隙连接蛋白的影响
11.Studies of the Functions of the Transmembrane Adapter Protein Cbp in Receptor Tyrosine Kinases Related Signal Transduction and Cell Activities;跨膜接头蛋白Cbp在受体型酪氨酸激酶相关信号转导和细胞活动中的功能研究
12.Protein Tyrosine Kinase Inhibitor Genistein to Suppress Invasion of Human Lung Adenocarcinoma Cell Line A549 in vitro蛋白酪氨酸激酶抑制剂Genistein抑制肺癌细胞A549体外侵袭作用的研究
13.Prevalence and Clinical Significance of Type Ⅲ Receptor Tyrosine Kinases in Acute Leukemia;Ⅲ型受体酪氨酸激酶与急性白血病的关系及临床意义
14.The Significance of Expression Angs/Tie-2 System in Leukemia;白血病患者中血管生成素/受体酪氨酸激酶的表达及其意义
15.The name is soluble f-m-s-like tyrosine kinase one?这种蛋白质叫做可溶解fms样酪氨酸激酶一，
16.Tec Tyrosine Protein Kinase Involved in Multidrug Resistance of Hepatocelluar Carcinoma;Tec酪氨酸蛋白激酶参与肝癌多药耐药的研究
17.Study on the Prevalence of Protein Tyrosine Kinase JAK2V617F Mutation in the Western Population;西方人群中蛋白质酪氨酸激酶JAK2~（V617F）突变率研究
18.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
相关短句/例句
RPTK受体型蛋白酪氨酸激酶
3)receptor tyrosine protein kinase受体酪氨酸蛋白激酶
1.Recent emerging evidence suggests that the activiation ofreceptor tyrosine protein kinase induced by phosphatidylinositol 3-kinase,protein kinase C and Ca2+ plays a key role in the development of CNV.研究证实,磷脂酰肌醇激酶、蛋白激酶C和Ca2+等参与活化受体酪氨酸蛋白激酶的信号通路,以及受体酪氨酸蛋白激酶的持续活化对CNV的发生发展起关键性作用。
2.Receptor tyrosine protein kinase is one of key kinases in cell signal transduction and plays an important role in the process of cell growth, development and functions regulated by growth factors.受体酪氨酸蛋白激酶是细胞信号转导进行的关键信号酶,在生长因子调控细胞生长、发育与功能的过程中起着重要的生理作用。
4)receptor protein tyrosine kinase受体蛋白酪氨酸激酶
5)trkA酪氨酸蛋白激酶受体A
1.Expression of NGF andtrkA mRNAs in dogs’ periodontal tissue with traumatic occlusion;神经生长因子及酪氨酸蛋白激酶受体AmRNA在创伤咬合犬牙周组织中的表达
6)Tyrosine kinase receptor B酪氨酸蛋白激酶受体B
1.Expression of tyrosine kinase receptor B in human follicle;酪氨酸蛋白激酶受体B在人卵泡中的表达及意义
2.BDNF initiate its biological effects by bounding to tyrosine kinase receptor B (TrkB) on the cell membrane.目的：关于人卵泡液中存在着由卵丘颗粒细胞分泌的脑源性神经营养因子(BDNF)的报道提示：人卵巢中可能有BDNF赖以发挥其生物学效应的特异性高亲合力受体—酪氨酸蛋白激酶受体B(TrkB)的存在。
延伸阅读
酪氨酸蛋白激酶抑制剂分子式：CAS号：性质：一类能抑制蛋白质酪氨酸激酶活性的化合物。酪氨酸蛋白激酶能特异性地将磷酸根转移到蛋白质的酪氨酸残基上使其磷酸化，是许多配体活化的生长因子受体和一些癌基因产物，在肿瘤组织中含量高。酪氨酸蛋白激酶抑制剂可作为ATP与酪氨酸蛋白激酶结合的竞争性抑制剂，也可作为酪氨酸的类似物阻断表皮生长因子受体的肽位点和酪氨酸蛋白激酶的编码，抑制细胞增殖，可望开发为抗肿瘤药物，但对完整细胞没有表现出选择性。
